Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 156.9B | 169.3B | 157.3B | 150.0B |
Cost of revenue | 133.8B | 156.6B | 133.7B | 128.1B |
Gross profit | 23.1B | 12.7B | 23.6B | 21.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 8.5B | 4.4B | 2.7B | 2.5B |
Other operating expenses | — | 596.7M | 25.2M | 180.5M |
Operating income | 23.1B | -459.5M | 16.2B | 14.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 14.8B | 1.5B | 17.2B | 15.3B |
Tax provision | 3.3B | -1.4B | 3.9B | 3.8B |
Net income | 11.4B | 2.9B | 13.3B | 11.4B |
Basic EPS | 3.7K | — | 4.3K | 3.7K |
Diluted EPS | 3.7K | — | 4.3K | 3.7K |
Basic average shares | — | — | 3.1M | 3.1M |
Diluted average shares | — | — | 3.1M | 3.1M |
EBITDA | 23.1B | 12.5B | 22.7B | 20.7B |
Net income from continuing op. | — | 2.9B | 13.3B | 11.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |